Chengdong Huo
Overview
Explore the profile of Chengdong Huo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
26
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang X, Wei Y, Wu F, Li M, Han C, Huo C, et al.
J Cancer Res Clin Oncol
. 2024 Apr;
150(4):210.
PMID: 38656363
Purpose: Gastric cancer (GC) is prevalent as one of the most common malignant tumors globally, with a particularly high incidence in China. The role of UBE2L3 in the initiation and...
2.
Huo C, Gu Y, Wang D, Zhang X, Tang F, Zhao B, et al.
J Cancer Res Clin Oncol
. 2023 Aug;
149(17):15335-15348.
PMID: 37639009
Purpose: Tripartite motif-containing protein 21 (TRIM21) has E3 ubiquitin ligase activity and is involved in the regulation of various biological processes in vivo. TRIM21 has been found to have strong...
3.
Huo C, Zhang X, Gu Y, Wang D, Zhang S, Liu T, et al.
Biomolecules
. 2023 May;
13(5).
PMID: 37238742
Gastric organoids are biological models constructed in vitro using stem cell culture and 3D cell culture techniques, which are the latest research hotspots. The proliferation of stem cells in vitro...
4.
Wang D, Gu Y, Huo C, Zhao Y, Teng M, Li Y
Gene
. 2022 Jul;
840:146760.
PMID: 35905854
Background: Over the last decade, breakthroughs have been made in cancer immunotherapy. However, for advanced gastric cancer (AGC), the complexity and heterogeneity of the tumor microenvironment (TME) has been the...
5.
Wang D, Gu Y, Yan X, Huo C, Wang G, Zhao Y, et al.
Front Oncol
. 2022 Apr;
12:844260.
PMID: 35433470
The tumor microenvironment restricts the function and survival of various immune cells by up-regulating inhibitory immune checkpoints, and participates in the immune escape of tumors. The development of immunotherapies targeting...
6.
Zhang X, Huo C, Liu Y, Su R, Zhao Y, Li Y
Front Immunol
. 2022 Mar;
13:793610.
PMID: 35265070
Ubiquitin conjugating enzyme E2 is an important component of the post-translational protein ubiquitination pathway, which mediates the transfer of activated ubiquitin to substrate proteins. UBE2L3, also called UBcH7, is one...